Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?24/7 Wall Street • 02/07/25
Merck & Co., Inc. (MRK) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 02/07/25
Investors who lost money on Merck & Co., Inc. should contact Levi & Korsinsky about an ongoing investigation - MRKAccesswire • 02/06/25
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell LymphomaBusiness Wire • 02/06/25
Merck & Co., Inc. (MRK) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesAccesswire • 02/04/25
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 ViewZacks Investment Research • 02/04/25
Merck shares plunge on weak 2025 outlook, pause in Gardasil shipments to ChinaProactive Investors • 02/04/25
Merck (MRK) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/04/25
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 OutlookBenzinga • 02/04/25
Merck Canada urges Canadians to take action for their lung health with new “Listen Close” campaignBusiness Wire • 02/04/25